<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34059131</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2047-9158</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>May</Month><Day>31</Day></PubDate></JournalIssue><Title>Translational neurodegeneration</Title><ISOAbbreviation>Transl Neurodegener</ISOAbbreviation></Journal><ArticleTitle>Disruption of orbitofrontal-hypothalamic projections in a murine ALS model and in human patients.</ArticleTitle><Pagination><StartPage>17</StartPage><MedlinePgn>17</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">17</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40035-021-00241-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">Increased catabolism has recently been recognized as a clinical manifestation of amyotrophic lateral sclerosis (ALS). The hypothalamic systems have been shown to be involved in the metabolic dysfunction in ALS, but the exact extent of hypothalamic circuit alterations in ALS is yet to be determined. Here we explored the integrity of large-scale cortico-hypothalamic circuits involved in energy homeostasis in murine models and in ALS patients.</AbstractText><AbstractText Label="METHODS">The rAAV2-based large-scale projection mapping and image analysis pipeline based on Wholebrain and Ilastik software suites were used to identify and quantify projections from the forebrain to the lateral hypothalamus in the SOD1(G93A) ALS mouse model (hypermetabolic) and the Fus<sup>&#x394;NLS</sup> ALS mouse model (normo-metabolic). 3&#x2009;T diffusion tensor imaging (DTI)-magnetic resonance imaging (MRI) was performed on 83 ALS and 65 control cases to investigate cortical projections to the lateral hypothalamus (LHA) in ALS.</AbstractText><AbstractText Label="RESULTS">Symptomatic SOD1(G93A) mice displayed an expansion of projections from agranular insula, ventrolateral orbitofrontal and secondary motor cortex to the LHA. These findings were reproduced in an independent cohort by using a different analytic approach. In contrast, in the Fus<sup>&#x394;NLS</sup> ALS mouse model hypothalamic inputs from insula and orbitofrontal cortex were maintained while the projections from motor cortex were lost. The DTI-MRI data confirmed the disruption of the orbitofrontal-hypothalamic tract in ALS patients.</AbstractText><AbstractText Label="CONCLUSION">This study provides converging murine and human data demonstrating the selective structural disruption of hypothalamic inputs in ALS as a promising factor contributing to the origin of the hypermetabolic phenotype.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bayer</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CEMMA (Cellular and Molecular Mechanisms in Aging) Research Training Group, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonucci</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Hans-Peter</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saad</LastName><ForeName>Rami</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dupuis</LastName><ForeName>Luc</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Strasbourg, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasche</LastName><ForeName>Volker</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Ulm University Medical Centre, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xf6;ckers</LastName><ForeName>Tobias M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Institute of Anatomy and Cell Biology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases-DZNE, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ludolph</LastName><ForeName>Albert C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases-DZNE, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kassubek</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases-DZNE, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roselli</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-9935-6899</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany. francesco.roselli@uni-ulm.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases-DZNE, Ulm, Germany. francesco.roselli@uni-ulm.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>251293561</GrantID><Agency>Deutsche Forschungsgemeinschaft</Agency><Country/></Grant><Grant><GrantID>431995586</GrantID><Agency>Deutsche Forschungsgemeinschaft</Agency><Country/></Grant><Grant><GrantID>GRK 1789/2</GrantID><Agency>Deutsche Forschungsgemeinschaft</Agency><Country/></Grant><Grant><GrantID>443642953</GrantID><Agency>Deutsche Forschungsgemeinschaft</Agency><Country/></Grant><Grant><GrantID>01EW1705A</GrantID><Agency>Bundesministerium f&#xfc;r Bildung und Forschung</Agency><Country/></Grant><Grant><GrantID>TriALS</GrantID><Agency>Fondation Thierry Latran</Agency><Country/></Grant><Grant><GrantID>Hypothals</GrantID><Agency>Fondation Thierry Latran</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Transl Neurodegener</MedlineTA><NlmUniqueID>101591861</NlmUniqueID><ISSNLinking>2047-9158</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599551">FUS protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C000606291">Sod1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001931" MajorTopicYN="N">Brain Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056324" MajorTopicYN="N">Diffusion Tensor Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004734" MajorTopicYN="N">Energy Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007031" MajorTopicYN="N">Hypothalamus</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009044" MajorTopicYN="N">Motor Cortex</DescriptorName><QualifierName UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009434" MajorTopicYN="N">Neural Pathways</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017397" MajorTopicYN="N">Prefrontal Cortex</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Agranular insula</Keyword><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Hypermetabolism</Keyword><Keyword MajorTopicYN="N">Lateral hypothalamus</Keyword><Keyword MajorTopicYN="N">Orbitofrontal cortex</Keyword><Keyword MajorTopicYN="N">rAAV2</Keyword></KeywordList><CoiStatement>The authors declare no financial interest or conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>5</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34059131</ArticleId><ArticleId IdType="pmc">PMC8168014</ArticleId><ArticleId IdType="doi">10.1186/s40035-021-00241-6</ArticleId><ArticleId IdType="pii">10.1186/s40035-021-00241-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3(1):17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Pradat PF, Ludolph AC, Loeffler JP. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 2011;10(1):75&#x2013;82. doi: 10.1016/S1474-4422(10)70224-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70224-6</ArticleId><ArticleId IdType="pubmed">21035400</ArticleId></ArticleIdList></Reference><Reference><Citation>Peter RS, Rosenbohm A, Dupuis L, Brehme T, Kassubek J, Rothenbacher D, et al. Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia. Eur J Epidemiol. 2017;32(10):901&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">28975435</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo V, Wark PA, Jenab M, Pearce N, Brayne C, Vermeulen R, Andersen PM, Hallmans G, Kyrozis A, Vanacore N, Vahdaninia M, Grote V, Kaaks R, Mattiello A, Bueno-de-Mesquita HB, Peeters PH, Travis RC, Petersson J, Hansson O, Arriola L, Jimenez-Martin JM, Tjonneland A, Halkjaer J, Agnoli C, Sacerdote C, Bonet C, Trichopoulou A, Gavrila D, Overvad K, Weiderpass E, Palli D, Quiros JR, Tumino R, Khaw KT, Wareham N, Barricante-Gurrea A, Fedirko V, Ferrari P, Clavel-Chapelon F, Boutron-Ruault MC, Boeing H, Vigl M, Middleton L, Riboli E, Vineis P. Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort. Neurology. 2013;80(9):829&#x2013;838. doi: 10.1212/WNL.0b013e3182840689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182840689</ArticleId><ArticleId IdType="pmc">PMC3598455</ArticleId><ArticleId IdType="pubmed">23390184</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Corcia P, Fergani A. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008;70(13):1004&#x2013;1009. doi: 10.1212/01.wnl.0000285080.70324.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000285080.70324.27</ArticleId><ArticleId IdType="pubmed">18199832</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J, K&#xfc;hnlein P, Hendrich C, Kassubek J, Sperfeld AD, Ludolph AC. Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J Neurol. 2011;258(4):613&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">21128082</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindauer E, Dupuis L, M&#xfc;ller HP, Neumann H, Ludolph AC, Kassubek J. Adipose tissue distribution predicts survival in amyotrophic lateral sclerosis. PLoS One. 2013;8(6):e67783. doi: 10.1371/journal.pone.0067783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0067783</ArticleId><ArticleId IdType="pmc">PMC3694869</ArticleId><ArticleId IdType="pubmed">23826340</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, Desport JC, Kajeu P, Jesus P, Nicolaud B, Nicol M, et al. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry. 2011;82(6):628&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">21097551</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn FJ, Ioannides ZA, van Eijk RPA, Heggie S, Thorpe KA, Ceslis A, et al. Hypermetabolism in ALS is associated with greater functional decline and shorter survival. J Neurol Neurosurg Psychiatry. 2018;89(10):1016&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6166607</ArticleId><ArticleId IdType="pubmed">29706605</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe9;sus P, Fayemendy P, Nicol M, Lautrette G, Sourisseau H, Preux PM, et al. Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2018;25(1):97&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">28940704</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed RM, Irish M, Piguet O, Halliday GM, Ittner LM, Farooqi S, et al. Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism. Lancet Neurol. 2016;15(3):332&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">26822748</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport JC, Torny F, Lacoste M, Preux PM, Couratier P. Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neurodegener Dis. 2005;2(3&#x2013;4):202&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16909026</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouteloup C, Desport JC, Clavelou P, Guy N, Derumeaux-Burel H, Ferrier A, et al. Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol. 2009;256(8):1236&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">19306035</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Oudart H, Ren&#xe9; F. Gonzalez de Aguilar JL, Loeffler JP. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci U S A. 2004;101(30):11159&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC503756</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim MA, Bence KK, Sandesara I, Andreux P, Auwerx J, Ishibashi J, Seale P, Kalb RG. Genetically altering organismal metabolism by leptin-deficiency benefits a mouse model of amyotrophic lateral sclerosis. Hum Mol Genet. 2014;23(18):4995&#x2013;5008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4140473</ArticleId><ArticleId IdType="pubmed">24833719</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaricamazza S, Salvatori I, Giacovazzo G, Loeffler JP, Ren&#xe8; F, Rosina M, et al. Skeletal-muscle metabolic reprogramming in ALS-SOD1G93A mice predates disease onset and is a promising therapeutic target. iScience. 2020;23(5):101087. doi: 10.1016/j.isci.2020.101087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101087</ArticleId><ArticleId IdType="pmc">PMC7200935</ArticleId><ArticleId IdType="pubmed">32371370</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph AC, Dorst J, Dreyhaupt J, Weishaupt JH, Kassubek J, Weiland U, et al. Effect of high-caloric nutrition on survival in amyotrophic lateral sclerosis. Ann Neurol. 2020;87(2):206&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">31849093</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J, Schuster J, Dreyhaupt J, Witzel S, Weishaupt JH, Kassubek J, et al. Effect of high-caloric nutrition on serum neurofilament light chain levels in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2020;91(9):1007&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">32788256</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorges M, Vercruysse P, M&#xfc;ller HP, Huppertz HJ, Rosenbohm A, Nagel G, et al. Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2017;88(12):1033&#x2013;1041.</Citation><ArticleIdList><ArticleId IdType="pubmed">28596251</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabery S, Ahmed RM, Caga J, Kiernan MC, Halliday GM, Peters&#xe9;n &#xc5;. Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol. 2021. 10.1111/nan.12709.</Citation><ArticleIdList><ArticleId IdType="pubmed">33755993</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez JA, Iordanidou P, Strom M, Adamantidis A, Burdakov D. Awake dynamics and brain-wide direct inputs of hypothalamic MCH and orexin networks. Nat Commun. 2016;7(1):11395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4844703</ArticleId><ArticleId IdType="pubmed">27102565</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbier M, Chometton S, Pautrat A, Miguet-Alfonsi C, Datiche F, Gascuel J, et al. A basal ganglia-like cortical-amygdalar-hypothalamic network mediates feeding behavior. Proc Natl Acad Sci U S A. 2020;117(27):15967&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7354999</ArticleId><ArticleId IdType="pubmed">32571909</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbier M, Gonz&#xe1;lez JA, Houdayer C, Burdakov D, Risold PY, Croizier S. Projections from the dorsomedial division of the bed nucleus of the stria terminalis to hypothalamic nuclei in the mouse. J Comp Neurol. 2020. 10.1002/cne.24988.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7891577</ArticleId><ArticleId IdType="pubmed">32678476</ArticleId></ArticleIdList></Reference><Reference><Citation>Murata K, Kinoshita T, Fukazawa Y, Kobayashi K, Kobayashi K, Miyamichi K, et al. GABAergic neurons in the olfactory cortex projecting to the lateral hypothalamus in mice. Sci Rep. 2019;9(1):7132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6509143</ArticleId><ArticleId IdType="pubmed">31073137</ArticleId></ArticleIdList></Reference><Reference><Citation>Berthoud HR. Multiple neural systems controlling food intake and body weight. Neurosci Biobehav Rev. 2002;26(4):393&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pubmed">12204189</ArticleId></ArticleIdList></Reference><Reference><Citation>Commisso B, Ding L, Varadi K, Gorges M, Bayer D, Boeckers TM, et al. Stage-dependent remodeling of projections to motor cortex in ALS mouse model revealed by a new variant retrograde-AAV9. Elife. 2018;7:e36892.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6125125</ArticleId><ArticleId IdType="pubmed">30136928</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Canu E, Valsasina P, Riva N, Prelle A, Comi G, et al. Divergent brain network connectivity in amyotrophic lateral sclerosis. Neurobiol Aging. 2013;34(2):419&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">22608240</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthess I, Gorges M, M&#xfc;ller HP, Lul&#xe9; D, Del Tredici K, Ludolph AC, et al. Functional connectivity changes resemble patterns of pTDP-43 pathology in amyotrophic lateral sclerosis. Sci Rep. 2016;6(1):38391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5144012</ArticleId><ArticleId IdType="pubmed">27929102</ArticleId></ArticleIdList></Reference><Reference><Citation>Heimrath J, Gorges M, Kassubek J, M&#xfc;ller HP, Birbaumer N, Ludolph AC, et al. Additional resources and the default mode network: evidence of increased connectivity and decreased white matter integrity in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(7&#x2013;8):537&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">24862983</ArticleId></ArticleIdList></Reference><Reference><Citation>Dukic S, McMackin R, Buxo T, Fasano A, Chipika R, Pinto-Grau M, et al. Patterned functional network disruption in amyotrophic lateral sclerosis. Hum Brain Mapp. 2019;40(16):4827&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6852475</ArticleId><ArticleId IdType="pubmed">31348605</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Brettschneider J, Ludolph AC, Lee VM, Trojanowski JQ, Del Tredici K. Amyotrophic lateral sclerosis--a model of corticofugal axonal spread. Nat Rev Neurol. 2013;9(12):708&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3943211</ArticleId><ArticleId IdType="pubmed">24217521</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Del Tredici K, Toledo JB, Robinson JL, Irwin DJ, Grossman M, et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol. 2013;74(1):20&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264(5166):1772&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J, Sendscheid O, El Oussini H, Jambeau M, Sun Y, Mersmann S, et al. Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss. EMBO J. 2016;35(10):1077&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4868956</ArticleId><ArticleId IdType="pubmed">26951610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouali Alami N, Schurr C, Olde Heuvel F, Tang L, Li Q, Tasdogan A, et al. NF-&#x3ba;B activation in astrocytes drives a stage-specific beneficial neuroimmunological response in ALS. EMBO J. 2018;37(16):e98697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6092622</ArticleId><ArticleId IdType="pubmed">29875132</ArticleId></ArticleIdList></Reference><Reference><Citation>Tervo DG, Hwang BY, Viswanathan S, Gaj T, Lavzin M, Ritola KD, et al. A designer AAV variant permits efficient retrograde access to projection neurons. Neuron. 2016;92(2):372&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5872824</ArticleId><ArticleId IdType="pubmed">27720486</ArticleId></ArticleIdList></Reference><Reference><Citation>Madisen L, Garner AR, Shimaoka D, Chuong AS, Klapoetke NC, Li L, et al. Transgenic mice for intersectional targeting of neural sensors and effectors with high specificity and performance. Neuron. 2015;85(5):942&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4365051</ArticleId><ArticleId IdType="pubmed">25741722</ArticleId></ArticleIdList></Reference><Reference><Citation>Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates. 2nd ed. San Diego: Academic Press; 2001.&#xa0;ISBN 0125476361, 9780125476362.</Citation></Reference><Reference><Citation>Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3855844</ArticleId><ArticleId IdType="pubmed">22743772</ArticleId></ArticleIdList></Reference><Reference><Citation>F&#xfc;rth D, Vaissi&#xe8;re T, Tzortzi O, Xuan Y, M&#xe4;rtin A, Lazaridis I, et al. An interactive framework for whole-brain maps at cellular resolution. Nat Neurosci. 2018;21(1):139&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5994773</ArticleId><ArticleId IdType="pubmed">29203898</ArticleId></ArticleIdList></Reference><Reference><Citation>Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A, et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature. 2007;445(7124):168&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">17151600</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg S, Kutra D, Kroeger T, Straehle CN, Kausler BX, Haubold C, et al. Ilastik: interactive machine learning for (bio) image analysis. Nat Methods. 2019;16(12):1226&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">31570887</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiaschi L, Koethe U, Nair R, Hamprecht FA. Learning to count with regression forest and structured labels. Proceedings of the 21st International Conference on Pattern Recognition (ICPR2012). Tsukuba. 2012;2685&#x2013;2688.</Citation></Reference><Reference><Citation>Sahoo P, Wilkins C, Yeager J. Threshold selection using Renyi's entropy. Pattern Recogn. 1997;30(1):71&#x2013;84. doi: 10.1016/S0031-3203(96)00065-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0031-3203(96)00065-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassubek J, M&#xfc;ller HP, Del Tredici K, Lul&#xe9; D, Gorges M, Braak H, et al. Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker. J Neurol Neurosurg Psychiatry. 2018;89(4):374&#x2013;381. doi: 10.1136/jnnp-2017-316365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-316365</ArticleId><ArticleId IdType="pmc">PMC5869447</ArticleId><ArticleId IdType="pubmed">29101254</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller HP, Unrath A, Ludolph AC, Kassubek J. Preservation of diffusion tensor properties during spatial normalization by use of tensor imaging and fibre tracking on a normal brain database. Phys Med Biol. 2007;52(6):N99&#x2013;N109. doi: 10.1088/0031-9155/52/6/N01.</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/0031-9155/52/6/N01</ArticleId><ArticleId IdType="pubmed">17327646</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller HP, Del Tredici K, Lul&#xe9; D, M&#xfc;ller K, Weishaupt JH, Ludolph AC, et al. In vivo histopathological staging in C9orf72-associated ALS: a tract of interest DTI study. Neuroimage Clin. 2020;27:102298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270604</ArticleId><ArticleId IdType="pubmed">32505118</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller HP, Unrath A, Sperfeld AD, Ludolph AC, Riecker A, Kassubek J. Diffusion tensor imaging and tractwise fractional anisotropy statistics: quantitative analysis in white matter pathology. Biomed Eng Online. 2007;6:42. doi: 10.1186/1475-925X-6-42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1475-925X-6-42</ArticleId><ArticleId IdType="pmc">PMC2186341</ArticleId><ArticleId IdType="pubmed">17996104</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrik MS, Wilson JM, Grant SC, Blackband SJ, Tabata RC, Shan X, et al. Magnetic resonance microscopy and immunohistochemistry of the CNS of the mutant SOD murine model of ALS reveals widespread neural deficits. NeuroMolecular Med. 2007;9(3):216&#x2013;229. doi: 10.1007/s12017-007-8002-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-007-8002-1</ArticleId><ArticleId IdType="pubmed">17914180</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J, Oussini HE, Mersmann S, Drenner K, Wagner M, Sun Y, et al. Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133(6):887&#x2013;906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5427169</ArticleId><ArticleId IdType="pubmed">28243725</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariosa D, Beard JD, Umbach DM, Bellocco R, Keller J, Peters TL, et al. Body mass index and amyotrophic lateral sclerosis: a study of US military veterans. Am J Epidemiol. 2017;185(5):362&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5860019</ArticleId><ArticleId IdType="pubmed">28158443</ArticleId></ArticleIdList></Reference><Reference><Citation>Vercruysse P, Vieau D, Blum D, Peters&#xe9;n &#xc5;, Dupuis L. Hypothalamic alterations in neurodegenerative diseases and their relation to abnormal energy metabolism. Front Mol Neurosci. 2018;11:2. doi: 10.3389/fnmol.2018.00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00002</ArticleId><ArticleId IdType="pmc">PMC5780436</ArticleId><ArticleId IdType="pubmed">29403354</ArticleId></ArticleIdList></Reference><Reference><Citation>Cykowski MD, Takei H, Schulz PE, Appel SH, Powell SZ. TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis. Acta Neuropathol Commun. 2014;2:171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4297460</ArticleId><ArticleId IdType="pubmed">25539830</ArticleId></ArticleIdList></Reference><Reference><Citation>Dedeene L, Van Schoor E, Vandenberghe R, Van Damme P, Poesen K, Thal DR. Circadian sleep/wake-associated cells show dipeptide repeat protein aggregates in C9orf72-related ALS and FTLD cases. Acta Neuropathol Commun. 2019;7(1):189. doi: 10.1186/s40478-019-0845-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0845-9</ArticleId><ArticleId IdType="pmc">PMC6889626</ArticleId><ArticleId IdType="pubmed">31791419</ArticleId></ArticleIdList></Reference><Reference><Citation>Vercruysse P, Sinniger J, El Oussini H, Scekic-Zahirovic J, Dieterl&#xe9; S, Dengler R, et al. Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis. Brain. 2016;139(Pt 4):1106&#x2013;1122. doi: 10.1093/brain/aww004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww004</ArticleId><ArticleId IdType="pubmed">26984187</ArticleId></ArticleIdList></Reference><Reference><Citation>Floyd NS, Price JL, Ferry AT, Keay KA, Bandler R. Orbitomedial prefrontal cortical projections to hypothalamus in the rat. J Comp Neurol. 2001;432(3):307&#x2013;328. doi: 10.1002/cne.1105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.1105</ArticleId><ArticleId IdType="pubmed">11246210</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoover WB, Vertes RP. Projections of the medial orbital and ventral orbital cortex in the rat. J Comp Neurol. 2011;519(18):3766&#x2013;3801. doi: 10.1002/cne.22733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.22733</ArticleId><ArticleId IdType="pubmed">21800317</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts AC, Tomic DL, Parkinson CH, Roeling TA, Cutter DJ, Robbins TW, et al. Forebrain connectivity of the prefrontal cortex in the marmoset monkey (Callithrix jacchus): an anterograde and retrograde tract-tracing study. J Comp Neurol. 2007;502(1):86&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">17335041</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong&#xfc;r D, An X, Price JL. Prefrontal cortical projections to the hypothalamus in macaque monkeys. J Comp Neurol. 1998;401(4):480&#x2013;505. doi: 10.1002/(SICI)1096-9861(19981130)401:4&lt;480::AID-CNE4&gt;3.0.CO;2-F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9861(19981130)401:4&lt;480::AID-CNE4&gt;3.0.CO;2-F</ArticleId><ArticleId IdType="pubmed">9826274</ArticleId></ArticleIdList></Reference><Reference><Citation>Price JL. Definition of the orbital cortex in relation to specific connections with limbic and visceral structures and other cortical regions. Ann N Y Acad Sci. 2007;1121(1):54&#x2013;71. doi: 10.1196/annals.1401.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1401.008</ArticleId><ArticleId IdType="pubmed">17698999</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander AL, Lee JE, Lazar M, Field AS. Diffusion tensor imaging of the brain. Neurotherapeutics. 2007;4(3):316&#x2013;329. doi: 10.1016/j.nurt.2007.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nurt.2007.05.011</ArticleId><ArticleId IdType="pmc">PMC2041910</ArticleId><ArticleId IdType="pubmed">17599699</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi M. Macroscopic connection of rat insular cortex: anatomical bases underlying its physiological functions. Int Rev Neurobiol. 2011;97:285&#x2013;303. doi: 10.1016/B978-0-12-385198-7.00011-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-385198-7.00011-4</ArticleId><ArticleId IdType="pubmed">21708315</ArticleId></ArticleIdList></Reference><Reference><Citation>Izquierdo A. Functional heterogeneity within rat orbitofrontal cortex in reward learning and decision making. J Neurosci. 2017;37(44):10529&#x2013;10540. doi: 10.1523/JNEUROSCI.1678-17.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1678-17.2017</ArticleId><ArticleId IdType="pmc">PMC6596524</ArticleId><ArticleId IdType="pubmed">29093055</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolls ET. The functions of the orbitofrontal cortex. Brain Cogn. 2004;55(1):11&#x2013;29. doi: 10.1016/S0278-2626(03)00277-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0278-2626(03)00277-X</ArticleId><ArticleId IdType="pubmed">15134840</ArticleId></ArticleIdList></Reference><Reference><Citation>Seabrook LT, Borgland SL. The orbitofrontal cortex, food intake and obesity. J Psychiatry Neurosci. 2020;45(5):304&#x2013;312. doi: 10.1503/jpn.190163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/jpn.190163</ArticleId><ArticleId IdType="pmc">PMC7850155</ArticleId><ArticleId IdType="pubmed">32167268</ArticleId></ArticleIdList></Reference><Reference><Citation>Schur EA, Kleinhans NM, Goldberg J, Buchwald D, Schwartz MW, Maravilla K. Activation in brain energy regulation and reward centers by food cues varies with choice of visual stimulus. Int J Obes. 2009;33(6):653&#x2013;661. doi: 10.1038/ijo.2009.56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ijo.2009.56</ArticleId><ArticleId IdType="pmc">PMC2697279</ArticleId><ArticleId IdType="pubmed">19365394</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki S, Cross L, O'Doherty JP. Elucidating the underlying components of food valuation in the human orbitofrontal cortex. Nat Neurosci. 2017;20(12):1780&#x2013;1786. doi: 10.1038/s41593-017-0008-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0008-x</ArticleId><ArticleId IdType="pmc">PMC6214455</ArticleId><ArticleId IdType="pubmed">29184201</ArticleId></ArticleIdList></Reference><Reference><Citation>Raji CA, Ho AJ, Parikshak NN, Becker JT, Lopez OL, Kuller LH, et al. Brain structure and obesity. Hum Brain Mapp. 2010;31(3):353&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2826530</ArticleId><ArticleId IdType="pubmed">19662657</ArticleId></ArticleIdList></Reference><Reference><Citation>Walther K, Birdsill AC, Glisky EL, Ryan L. Structural brain differences and cognitive functioning related to body mass index in older females. Hum Brain Mapp. 2010;31(7):1052&#x2013;1064. doi: 10.1002/hbm.20916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.20916</ArticleId><ArticleId IdType="pmc">PMC6870943</ArticleId><ArticleId IdType="pubmed">19998366</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkan A, Sahin I, Keskin L, Cikim AS, Karakas HM, Sigirci A, et al. Diffusion-weighted imaging features of brain in obesity. Magn Reson Imaging. 2008;26(4):446&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">18063337</ArticleId></ArticleIdList></Reference><Reference><Citation>Abramzon YA, Fratta P, Traynor BJ, Chia R. The overlapping genetics of amyotrophic lateral sclerosis and frontotemporal dementia. Front Neurosci. 2020;14:42. doi: 10.3389/fnins.2020.00042.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00042</ArticleId><ArticleId IdType="pmc">PMC7012787</ArticleId><ArticleId IdType="pubmed">32116499</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho WY, Agrawal I, Tyan SH, Sanford E, Chang WT, Lim K, et al. Dysfunction in nonsense-mediated decay, protein homeostasis, mitochondrial function, and brain connectivity in ALS-FUS mice with cognitive deficits. Acta Neuropathol Commun. 2021;9(1):9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7789430</ArticleId><ArticleId IdType="pubmed">33407930</ArticleId></ArticleIdList></Reference><Reference><Citation>de Munter J, Babaevskaya D, Wolters EC, Pavlov D, Lysikova E. Kalueff AV, et al. molecular and behavioural abnormalities in the FUS-tg mice mimic frontotemporal lobar degeneration: effects of old and new anti-inflammatory therapies. J Cell Mol Med. 2020;24(17):10251&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7520339</ArticleId><ArticleId IdType="pubmed">32667139</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>